Background/Aims: Even though delayed ischemic preconditioning (DIPC) has been reported to produce renal protection, the underlying mechanism remains poorly understood. We reported that a 15-minute renal ischemic preconditioning (IPC) 4 days before subsequent ischemia-reperfusion attenuated renal injury. Kidney dendritic cells (DCs) are abundant in the renal tubulointerstitium and, depending on their status, can induce immune activation or tolerance. The aim of the present study was to investigate the role of DCs in IPC of the kidney. Methods: Mouse kidneys were challenged by transient brief episodes of sublethal ischemia followed by subsequent prolonged ischemia. DC abundance and maturation in the spleen and kidney were measured by flow cytometry and immunohistochemical staining. To confirm the function of mature DCs in the renoprotective effect of IPC on renal ischemia-reperfusion injury, the A2 adenosine receptor (A2AR) antagonist SCH58261 was administered to stimulate DC maturation prior to assessment of renal functional and histological injury and the inflammatory reaction. Results: Compared with sham-operated animals, preconditioned mice had a reduced injury with less CD11c(+) cells, lower levels of the pro-inflammatory cytokine IL-17 and reduced expression of the mature DC marker CCR7. Preconditioned mice also produced more of the anti-inflammatory cytokine IL-10. Both renal cells and splenocytes from these mice had more DCs (CD451(+)/CD11c(+)/F4/80), but fewer of these DCs were mature (CD45(+)/CD11c(+)/ F4/80(-)/MHC-II+/CD80(+)) compared with those from sham-treated animals, suggesting that the immunomodulatory effect of renal ischemic preconditioning is both local and systemic. Additionally, injection of the A2AR antagonist SCH58261 reversed IPC-induced inhibition of DC maturation and mitigated the protective effect of preconditioning, suggesting that DC maturation contributes to immune cell-mediated ischemic preconditioning. Conclusion: Our results show that DIPC of the kidney provides local and systemic immunosuppression by inhibiting DC maturation and hence mediates a renal protective effect. (C) 2018 The Author(s) Published by S. Karger AG, Basel
[1]Fudan Univ, Zhongshan Hosp, Div Nephrol, Shanghai, Peoples R China.
[2]Shanghai Med Ctr Kidney Dis, Shanghai, Peoples R China.
[3]Shanghai Key Lab Kidney & Hemodialysis, Shanghai, Peoples R China.
[4]Ningxia Med Univ, Gen Hosp, Dept Nephrol, Ningxia, Peoples R China.
[5]Shanghai Inst Kidney & Dialysis, Shanghai, Peoples R China.
(8.0+极速模式)